Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Gynecology

Free Subscription 01.11.2021 4 Acta Obstet Gynecol Scand 11 Am J Obstet Gynecol 1 Am J Surg Pathol 4 Aust N Z J Obstet Gynaecol 4 BMC Cancer 1 BMJ 3 Br J Cancer 2 Br J Radiol 1 Cancer Lett 4 Clin Cancer Res 1 Diagn Cytopathol 4 Eur J Obstet Gynecol Reprod Biol 7 Gynecol Endocrinol 13 Gynecol Oncol 2 Int J Cancer 13 Int J Gynaecol Obstet 82 Int J Radiat Oncol Biol Phys 3 J Clin Endocrinol Metab 3 J Urol 3 JAMA 1 Lancet 2 Obstet Gynecol 1 PLoS Comput Biol 6 PLoS One 6 Urol Clin North Am

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Obstet Gynecol Scand

1. COLLINS A, Motiwale T, Barney O, Dudbridge F, et al
   Impact of past obstetric history and cervical excision on preterm birth rate.
   Acta Obstet Gynecol Scand. 2021;100:1995-2002.
   PubMed         Abstract available
   
   
2. BALKO J, Novackova M, Skapa P, Pastor Z, et al
   Histopathological examination of the ectocervical biopsy in non-transplanted uteri: A study contributing to the provisional scoring system of subclinical graft rejection after uterus transplantation.
   Acta Obstet Gynecol Scand. 2021 Oct 25. doi: 10.1111/aogs.14280.
   PubMed         Abstract available
   
   
3. GRONVALL L, Skjeldestad FE
   Changed definition of disease and broader screening criteria had little impact on prevalence of gestational diabetes mellitus.
   Acta Obstet Gynecol Scand. 2021 Oct 26. doi: 10.1111/aogs.14276.
   PubMed         Abstract available
   
   
4. ACHARYA G, Sterpu I, Herling L
   Training future specialists in Obstetrics and Gynecology: Is harmonization possible in Europe?
   Acta Obstet Gynecol Scand. 2021;100:1939-1940.
   PubMed        
   
   

   
   Am J Obstet Gynecol

5. HUSBY KR, Gradel KO, Klarskov N
   Pelvic organ prolapse following hysterectomy on benign indication: a nationwide, nulliparous cohort study.
   Am J Obstet Gynecol. 2021 Oct 21. pii: S0002-9378(21)01123.
   PubMed         Abstract available
   
   
6. DONEPUDI R, Hessami K, Nassr AA, Espinoza J, et al
   Selective Reduction in Complicated Monochorionic Pregnancies: A Systematic Review and Meta-analysis of Different Techniques.
   Am J Obstet Gynecol. 2021 Oct 19. pii: S0002-9378(21)01119.
   PubMed         Abstract available
   
   
7. DE MIGUEL-GOMEZ L, Romeu M, Castells-Ballester J, Pellicer N, et al
   Undetectable viral RNA from SARS-CoV-2 in endometrial biopsies from women with COVID-19: a preliminary study.
   Am J Obstet Gynecol. 2021 Oct 21. pii: S0002-9378(21)01120.
   PubMed        
   
   
8. VOTO LS, Zeitune MG
   Statins to prevent or treat preeclampsia: sometimes it is too late.
   Am J Obstet Gynecol. 2021 Oct 18. pii: S0002-9378(21)01115.
   PubMed        
   
   
9. MATSUZAKI S, Mandelbaum RS, Matsuo K
   Is twin gestation an independent risk factor for placenta accreta spectrum: a response.
   Am J Obstet Gynecol. 2021 Oct 23. pii: S0002-9378(21)01149.
   PubMed        
   
   
10. GUO Z, Ma J, Yang H
    Is twin gestation an independent risk factor for placenta accreta spectrum?
    Am J Obstet Gynecol. 2021 Oct 23. pii: S0002-9378(21)01152.
    PubMed        
    
    
11. NAGABHUSHANA P, Sarkar A, Wadhawan I
    Letter to the Editor RE: COVID-19 vaccination during pregnancy: Coverage and Safety.
    Am J Obstet Gynecol. 2021 Oct 23. pii: S0002-9378(21)01154.
    PubMed        
    
    
12. SARKAR A, Chawla R, Thakur V
    Letter to the Editor RE: Worse Outcomes of Pregnancy in COVID-19 Infection during Parturition may be due to Referral Bias: Analysis in a Prospective Cohort of 963 pregnancies.
    Am J Obstet Gynecol. 2021 Oct 23. pii: S0002-9378(21)01153.
    PubMed        
    
    
13. MASSAD LS, Xie X, Minkoff HL, Michel KG, et al
    Frequency of high-grade squamous cervical lesions among women over age 65 years living with HIV.
    Am J Obstet Gynecol. 2021;225:411.
    PubMed         Abstract available
    
    
14. BOYD BAJ, Winkelman WD, Mishra K, Vittinghoff E, et al
    Racial and ethnic differences in reconstructive surgery for apical vaginal prolapse.
    Am J Obstet Gynecol. 2021;225:405.
    PubMed         Abstract available
    
    
15. MOHINI M, Ahmed S, Rath SK
    Interpreting COVID-19 Outcomes in Pregnancy Needs Knowledge of Prevalent Conditions in that Time-frame.
    Am J Obstet Gynecol. 2021 Oct 22. pii: S0002-9378(21)01150.
    PubMed        
    
    

    
    Am J Surg Pathol

16. AHVENAINEN T, Kaukomaa J, Kampjarvi K, Uimari O, et al
    Comparison of 2SC, AKR1B10, and FH Antibodies as Potential Biomarkers for FH-deficient Uterine Leiomyomas.
    Am J Surg Pathol. 2021 Oct 25. pii: 00000478-900000000-97109.
    PubMed         Abstract available
    
    

    
    Aust N Z J Obstet Gynaecol

17. MASTRANGELO M, Turnbull D
    The impact of surgically diagnosed symptomatic endometriosis on women's social lives, work and education: An inductive classical content analysis.
    Aust N Z J Obstet Gynaecol. 2021 Oct 22. doi: 10.1111/ajo.13447.
    PubMed         Abstract available
    
    
18. FRAWLEY N, Jones R, Pearce D, Vollenhoven B, et al
    The effect of intraperitoneal ropivacaine on post-operative pain and recovery after diagnostic laparoscopy and hysteroscopy: A randomised double-blind placebo-controlled trial.
    Aust N Z J Obstet Gynaecol. 2021 Oct 18. doi: 10.1111/ajo.13439.
    PubMed         Abstract available
    
    
19. SHRESTHA KHATRI N, White SW, Graham DF
    Associations between aspirin prophylaxis and fetal growth and preeclampsia in women with pregestational diabetes.
    Aust N Z J Obstet Gynaecol. 2021 Oct 22. doi: 10.1111/ajo.13449.
    PubMed         Abstract available
    
    
20. BALTUS T, Brown J, Kapurubandara S
    A retrospective cohort study of tubal occlusion or salpingectomy for permanent contraception in Australia.
    Aust N Z J Obstet Gynaecol. 2021 Oct 27. doi: 10.1111/ajo.13450.
    PubMed         Abstract available
    
    

    
    BMC Cancer

21. CREEDEN JF, Nanavaty NS, Einloth KR, Gillman CE, et al
    Homologous recombination proficiency in ovarian and breast cancer patients.
    BMC Cancer. 2021;21:1154.
    PubMed         Abstract available
    
    
22. GERNIER F, Ahmed-Lecheheb D, Pautier P, Floquet A, et al
    "Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovaria
    BMC Cancer. 2021;21:1147.
    PubMed         Abstract available
    
    
23. GAO L, Lyu J, Luo X, Zhang D, et al
    Nomogram to predict overall survival based on the log odds of positive lymph nodes for patients with endometrial carcinosarcoma after surgery.
    BMC Cancer. 2021;21:1149.
    PubMed         Abstract available
    
    
24. SHIMOI T, Hashimoto J, Sudo K, Shimomura A, et al
    Hotspot mutation profiles of AKT1 in Asian women with breast and endometrial cancers.
    BMC Cancer. 2021;21:1131.
    PubMed         Abstract available
    
    

    
    BMJ

25. SAUL H, Gursul D
    Women with kidney disease can be given a personal risk assessment for pregnancy.
    BMJ. 2021;375:n2526.
    PubMed         Abstract available
    
    

    
    Br J Cancer

26. XIE SH, Santoni G, Lagergren J
    Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study.
    Br J Cancer. 2021 Oct 20. pii: 10.1038/s41416-021-01575.
    PubMed         Abstract available
    
    
27. SI S, Li J, Tewara MA, Li H, et al
    Identifying causality, genetic correlation, priority and pathways of large-scale complex exposures of breast and ovarian cancers.
    Br J Cancer. 2021 Oct 20. pii: 10.1038/s41416-021-01576.
    PubMed         Abstract available
    
    
28. BLACKFORD AL, Childs EJ, Porter N, Petersen GM, et al
    A risk prediction tool for individuals with a family history of breast, ovarian, or pancreatic cancer: BRCAPANCPRO.
    Br J Cancer. 2021 Oct 26. pii: 10.1038/s41416-021-01580.
    PubMed         Abstract available
    
    

    
    Br J Radiol

29. BASTA NIKOLIC M, Spasic A, Hadnadjev Simonji D, Stojanovic S, et al
    Imaging of acute pelvic pain.
    Br J Radiol. 2021 Sep 7:20210281. doi: 10.1259/bjr.20210281.
    PubMed         Abstract available
    
    
30. TAKEUCHI M, Matsuzaki K, Harada M
    The feasibility of reduced field-of-view diffusion-weighted imaging in evaluating bladder invasion of uterine cervical cancer.
    Br J Radiol. 2021 Oct 27:20210692. doi: 10.1259/bjr.20210692.
    PubMed         Abstract available
    
    

    
    Cancer Lett

31. VENKATA PP, Chen Y, Alejo S, He Y, et al
    KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer.
    Cancer Lett. 2021;524:219-231.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

32. LHEUREUX S, Oaknin A, Garg S, Bruce JP, et al
    EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression.
    Clin Cancer Res. 2020 May 22. pii: 1078-0432.CCR-19-4121.
    PubMed         Abstract available
    
    
33. JI JX, Cochrane DR, Tessier-Cloutier B, Chen SY, et al
    Arginine depletion therapy with ADI-PEG20 limits tumor growth in argininosuccinate synthase deficient ovarian cancer, including small cell carcinoma of the ovary, hypercalcemic type.
    Clin Cancer Res. 2020 May 14. pii: 1078-0432.CCR-19-1905.
    PubMed         Abstract available
    
    
34. LAMPERT EJ, Zimmer AS, Padget MR, Cimino-Mathews A, et al
    Combination of PARP inhibitor olaparib, and PD-L1 inhibitor durvalumab, in recurrent ovarian cancer: a proof-of-concept phase 2 study.
    Clin Cancer Res. 2020 May 12. pii: 1078-0432.CCR-20-0056.
    PubMed         Abstract available
    
    
35. ARORA S, Narayan P, Ison G, Berman T, et al
    U.S. FDA Drug Approvals for Gynecological Malignancies - A Decade in Review.
    Clin Cancer Res. 2021 Oct 28. pii: 1078-0432.CCR-21-2599.
    PubMed         Abstract available
    
    

    
    Diagn Cytopathol

36. KABACA C, Giray B, Guray Uzun M, Akis S, et al
    The meaning of high-risk HPV other than type 16/18 in women with negative cytology: Is it really safe to wait for 1 year?
    Diagn Cytopathol. 2021;49:480-486.
    PubMed         Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

37. DUVILLIER C, Dard R, Herve B, Cohen C, et al
    Effects of the implementation of second-line prenatal cell-free DNA testing on termination of pregnancy in a French perinatal network.
    Eur J Obstet Gynecol Reprod Biol. 2021;267:36-41.
    PubMed         Abstract available
    
    
38. ADIB MOGHADDAM E, Kazemi A, Kheirabadi G, Ahmadi SM, et al
    Psychosocial consequences of oocyte donation in donors: A systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2021;267:28-35.
    PubMed         Abstract available
    
    
39. BOGANI G, Papadia A, Buda A, Casarin J, et al
    Factors predicting morbidity in surgically-staged high-risk endometrial cancer patients.
    Eur J Obstet Gynecol Reprod Biol. 2021;266:169-174.
    PubMed         Abstract available
    
    
40. LUCCHINI SM, Ferreyra HD, Landeros J, Esteban A, et al
    Conization and lymph node evaluation in low-risk cervical cancer. Is it time to avoid radical surgery? Retrospective series and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2021;266:163-168.
    PubMed         Abstract available
    
    

    
    Gynecol Endocrinol

41. SHI M, Huang W, Shu L, Hou G, et al
    Research on polycystic ovary syndrome: a bibliometric analysis from 2009 to 2019.
    Gynecol Endocrinol. 2021;37:121-125.
    PubMed         Abstract available
    
    
42. DORI-DAYAN N, Cukierman-Yaffe T, Kedar N, Zemet R, et al
    Maternal glucose variability during pregnancy & birthweight percentile in women with pre-gestational diabetes.
    Gynecol Endocrinol. 2021 Oct 21:1-5. doi: 10.1080/09513590.2021.1993814.
    PubMed         Abstract available
    
    
43. CARETTO M, Simoncini T
    Progestin or anti-estrogen treatment for endometrial cancer: choosing the best option for selected patients.
    Gynecol Endocrinol. 2021 Oct 26:1-2. doi: 10.1080/09513590.2021.1995964.
    PubMed        
    
    
44. INDHAVIVADHANA S, Boonyachan W, Rattanachaiyanont M, Wongwananuruk T, et al
    Effectiveness of vitamin D2 supplementation on high-sensitivity C-reactive protein and other metabolic indices in menopausal Thai women: a randomized-controlled trial.
    Gynecol Endocrinol. 2021 Oct 27:1-7. doi: 10.1080/09513590.2021.1988560.
    PubMed         Abstract available
    
    
45. ZAMANIYAN M, Peyvandi S, Heidaryan Gorji H, Moradi S, et al
    Effect of platelet-rich plasma on pregnancy outcomes in infertile women with recurrent implantation failure: a randomized controlled trial.
    Gynecol Endocrinol. 2021;37:141-145.
    PubMed         Abstract available
    
    
46. KARAMAN S, Sabanciogullari E, Karaman E, Basaranoglu M, et al
    Indicator of early kidney injury in adolescents with polycystic ovary syndrome: Can urine NGAL level be?
    Gynecol Endocrinol. 2021;37:117-120.
    PubMed         Abstract available
    
    
47. SHARMA P, Kaur M, Khetarpal P
    CYP19 gene rs2414096 variant and differential genetic risk of polycystic ovary syndrome: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2021;37:126-131.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

48. THOMAIER L, Darst BF, Jewett P, Hoffmann C, et al
    Genetic variants predictive of chemotherapy-induced peripheral neuropathy symptoms in gynecologic cancer survivors.
    Gynecol Oncol. 2021 Oct 18. pii: S0090-8258(21)01450.
    PubMed         Abstract available
    
    
49. MARTIN A, Wells A, Anderson ML, Chern JY, et al
    Trends in ureteral surgery on an academic gynecologic oncology service.
    Gynecol Oncol. 2021 Oct 18. pii: S0090-8258(21)01453.
    PubMed         Abstract available
    
    
50. MANYAM M, Stephens AJ, Kennard JA, LeBlanc J, et al
    A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer.
    Gynecol Oncol. 2021 Oct 19. pii: S0090-8258(21)01513.
    PubMed         Abstract available
    
    
51. HOROWITZ NS, Eskander RN, Adelman MR, Burke W, et al
    Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: A Society of Gynecologic Oncology evidenced-based review and recommendation.
    Gynecol Oncol. 2021 Oct 19. pii: S0090-8258(21)01421.
    PubMed        
    
    
52. HARRISON R, Zighelboim I, Cloven NG, Marcus JZ, et al
    Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement.
    Gynecol Oncol. 2021 Oct 19. pii: S0090-8258(21)01452.
    PubMed        
    
    
53. HE WQ, Li C
    Recent global burden of cervical cancer incidence and mortality, predictors, and temporal trends.
    Gynecol Oncol. 2021 Oct 20. pii: S0090-8258(21)01519.
    PubMed         Abstract available
    
    
54. GUDGEON JM, Wallentine JC, Bonham EM, McLaughlin HD, et al
    Determination of test performance of two contemporary screening tests for Lynch syndrome in endometrial cancer: A clinical trial.
    Gynecol Oncol. 2021 Oct 21. pii: S0090-8258(21)01401.
    PubMed         Abstract available
    
    
55. TREDAN O, Provansal M, Abdeddaim C, Lardy-Cleaud A, et al
    Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR).
    Gynecol Oncol. 2021 Oct 22. pii: S0090-8258(21)01402.
    PubMed         Abstract available
    
    
56. SHIN W, Park SY, Seo SS, Lim MC, et al
    Predicting the risk of the distant recurrence of cervical cancer after concurrent chemoradiation: A validation study of the Korean Gynecologic Oncologic Group (KGOG)-1024 model.
    Gynecol Oncol. 2021 Oct 22. pii: S0090-8258(21)01514.
    PubMed         Abstract available
    
    
57. BALAYA V, Guani B, Morice P, Querleu D, et al
    Long-term oncological safety of sentinel lymph node biopsy in early-stage cervical cancer: A post-hoc analysis of SENTICOL I and SENTICOL II cohorts.
    Gynecol Oncol. 2021 Oct 22. pii: S0090-8258(21)01518.
    PubMed         Abstract available
    
    
58. WITJES VM, van Bommel MHD, Ligtenberg MJL, Vos JR, et al
    Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis.
    Gynecol Oncol. 2021 Oct 23. pii: S0090-8258(21)01516.
    PubMed         Abstract available
    
    
59. WALTER A, Rocconi RP, Monk BJ, Herzog TJ, et al
    Gemogenovatucel-T (Vigil) maintenance immunotherapy: 3-year survival benefit in homologous recombination proficient (HRP) ovarian cancer.
    Gynecol Oncol. 2021 Oct 23. pii: S0090-8258(21)01422.
    PubMed         Abstract available
    
    
60. SOOVARES P, Pasanen A, Simila-Maarala J, Butzow R, et al
    Clinical factors and biomarker profiles associated with patient outcome in endometrioid ovarian carcinoma - Emphasis on tumor grade.
    Gynecol Oncol. 2021 Oct 25. pii: S0090-8258(21)01522.
    PubMed         Abstract available
    
    

    
    Int J Cancer

61. RAVEGNINI G, Gorini F, De Crescenzo E, De Leo A, et al
    Can miRNAs be useful biomarkers in improving prognostic stratification in endometrial cancer patients? An update review.
    Int J Cancer. 2021 Oct 27. doi: 10.1002/ijc.33857.
    PubMed         Abstract available
    
    
62. ISLAM S, Dutta P, Sahay O, Gopalakrishnan K, et al
    Feedback-regulated transcriptional repression of FBXO31 by c-Myc triggers ovarian cancer tumorigenesis.
    Int J Cancer. 2021 Oct 27. doi: 10.1002/ijc.33854.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

63. GIANNAKOULIS VG, Giannakodimos I, Kalampalikis A, Migklis K, et al
    Hybrid pediatric and adolescent gynecology telemedicine consultation in the era of COVID-19: Evaluation and feasibility.
    Int J Gynaecol Obstet. 2021 Oct 22. doi: 10.1002/ijgo.13995.
    PubMed         Abstract available
    
    
64. ALASHQAR A, Wildey B, Yazdy G, Goktepe ME, et al
    Predictors of same-day discharge after minimally invasive hysterectomy for benign indications.
    Int J Gynaecol Obstet. 2021 Oct 21. doi: 10.1002/ijgo.13992.
    PubMed         Abstract available
    
    
65. SHAZLY SA, Anan MA, Makukhina TB, Melekoglu R, et al
    Placenta accreta risk - antepartum score (PAR-A) in predicting clinical outcomes of placenta accreta spectrum: A multicenter validation study.
    Int J Gynaecol Obstet. 2021 Oct 21. doi: 10.1002/ijgo.13993.
    PubMed         Abstract available
    
    
66. QURESHI Z, Jamner A, Filippi V, Gwako G, et al
    Level and determinants of contraceptive uptake among women attending facilities with abortion-related complications in East and Southern Africa.
    Int J Gynaecol Obstet. 2021 Oct 22. doi: 10.1002/ijgo.13898.
    PubMed         Abstract available
    
    
67. EBOIGBE E, Gadama L, Filippi V, Mehrtash H, et al
    Adolescents' satisfaction with care for abortion-related complications in 11 Sub-Saharan African countries: A cross-sectional facility-based study.
    Int J Gynaecol Obstet. 2021 Oct 22. doi: 10.1002/ijgo.13896.
    PubMed         Abstract available
    
    
68. GIUDICE LC, Llamas-Clark EF, DeNicola N, Pandipati S, et al
    Climate change, women's health, and the role of obstetricians and gynecologists in leadership.
    Int J Gynaecol Obstet. 2021 Oct 25. doi: 10.1002/ijgo.13958.
    PubMed         Abstract available
    
    
69. MAIOR MDCFS, Souza ASR, Souza GFA, da Costa AAR, et al
    Comparison between 200 mug and 800 mug of vaginal misoprostol for cervical ripening prior to operative hysteroscopy: A randomized controlled trial.
    Int J Gynaecol Obstet. 2021 Oct 25. doi: 10.1002/ijgo.13984.
    PubMed         Abstract available
    
    
70. OLAWAIYE AB, Cuello MA, Rogers LJ
    Cancer of the vulva: 2021 update.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:7-18.
    PubMed         Abstract available
    
    
71. BHATLA N, Aoki D, Sharma DN, Sankaranarayanan R, et al
    Cancer of the cervix uteri: 2021 update.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:28-44.
    PubMed         Abstract available
    
    
72. ADAMS TS, Rogers LJ, Cuello MA
    Cancer of the vagina: 2021 update.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:19-27.
    PubMed         Abstract available
    
    
73. KOSKAS M, Amant F, Mirza MR, Creutzberg CL, et al
    Cancer of the corpus uteri: 2021 update.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:45-60.
    PubMed         Abstract available
    
    
74. NIETO-CALVACHE AJ, Palacios-Jaraquemada JM, Aguilera LR, Arriaga W, et al
    Telemedicine Facilitates Surgical Training in Placenta Accreta Spectrum.
    Int J Gynaecol Obstet. 2021 Oct 29. doi: 10.1002/ijgo.14000.
    PubMed         Abstract available
    
    
75. BRULL E, Costa Machado H, Bahamondes L, Juliato CRT, et al
    Expulsion and continuation rates of the levonorgestrel 52mg intrauterine system was similar among nulligravid and parous users.
    Int J Gynaecol Obstet. 2021 Oct 29. doi: 10.1002/ijgo.13998.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

76. MORCOS M, Bhatia R, Li K, Viswanathan AN, et al
    Prospective Trial of Hydrogel Visualization and Dosimetric Effects on Rectum and Tumor Dose in Gynecologic Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
77. AZGHADI S, Beagen PL, Ahmed A, Valicenti RK, et al
    Toxicity Related Patients Factors and Bevasizumab Use in Patients With Locally Advanced Cervical Cancer Treated With Definitive Chemoradiation and HDR Brachytherapy Boost.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
78. CHEN Y, Sun C, Li Q, Tang H, et al
    The Effect of Bulk Electron Density on the Accuracy of Treatment Planning for Postoperative Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
79. CHOQUE R, Aviles L, Rosas M, Suarez R, et al
    PET CT Based Stereotactic Body Radiosurgery (SBRT) in Non-Metastatic Cervical Cancer. The First Bolivian Experience.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
80. KOTHA NV, Williamson CW, Mell LK, Murphy JD, et al
    Racial Disparities in Time to Start of Definitive Radiation Treatment for Patients With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
81. AZGHADI S, Beagen PL, Ahmed A, Valicenti RK, et al
    Disparities and Health Access in Brachytherapy Boost Administration in Woman With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
82. FAHEY M, Mills MN, Liveringhouse C, Ronica N, et al
    Adherence to Endocrine Therapy Predicts Short-Term Clinical Outcomes for Postmenopausal Women With Luminal B but Not Luminal A Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
83. SHIAO JC, Santoso A, Stuhr K, Bennett S, et al
    Gynecologic Interstitial Brachytherapy Curriculum Using a Low-Cost Phantom With Ultrasound Workshop and a Treatment Planning Workshop is Feasible and Effective.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
84. D'CUNHA P, Gonzalez Y, Nwachukwu CR, Hrycushko BA, et al
    Change in Image-Guided Planning Strategies Over Time Impacts Global Outcomes for Intracavitary Cervical Cancer Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
85. COUSINS DF, Sanders J, Muller DA, Ward KA, et al
    Disease Characteristics and Patterns of Failure by Histologic Type for Patients Treated With Definitive Radiation for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
86. DING S, Liu H, Wang B, Li Y, et al
    Inter- and Intrafraction Bladder and Rectum Motion in Patients With Cervical Cancer Under MR-Guided Radiotherapy on a 1.5T MR-Linac.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
87. KOTHA NV, Williamson CW, McHale M, Mell LK, et al
    Ineligible and Incomplete Cisplatin Regimens in Chemoradiation Treatment for Patients With Locally Advanced Cervical Cancer: A Population for Survival Improvement.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
88. LEE TH, Kim IA, Kim JS Jr, Song C, et al
    Stereotactic Ablative Body Radiotherapy Boost for Cervical Cancer When Brachytherapy Boost is Not Feasible.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
89. KIM KH, Chang JS, Kim YB
    A Novel Gene Signature Associated With Poor Response to Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
90. KOERNER SA, Baig T, Kim H, Rodriguez-Lopez JL, et al
    Can We Avoid Ureters as Organs at Risk With MRI-Based Brachytherapy for Cervical Cancer? A Dosimetric Feasibility Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
91. GJYSHI O, Grippin A, Boyce-Fappiano D, Jhingran A, et al
    Circulating and Tumor-Associated Neutrophils Function as a Powerful Biomarker for Response to Chemoradiation in Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
92. HOLLIS ES, Ruebush E, Davies E, Paraghamian S, et al
    Smoking Cessation Interventions During Chemoradiotherapy for Locally Advanced Cervical Cancer: A Missed Opportunity?
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
93. GEORGE J, Tuli S, Monare B, Lichter K, et al
    Stage and Outcomes of Cervical Cancer With or Without HIV Infection in Botswana 2013-2020.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
94. FREIJE S, Steele EM, Robertson SE, Ishaq O Jr, et al
    Medicaid Expansion Through the Affordable Care Act and Receipt of Guideline Recommended Brachytherapy for Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
95. ORIAN IB, Symon Z, Appel S, Nof EL, et al
    The Impact of Radiation Therapy on Obstetric Complications in Cancer Survivors.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
96. URBAN R, Wong J, Lim P, Zhang S, et al
    Cervical Cancer Patient Reported Gastrointestinal Outcomes: Intensity/Volumetric Modulated vs. 3D Conformal Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
97. ROGACKI K, Wray B, Donnelly ED
    Gene Expression and Mutation Analysis of Early-Stage Recurrent Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
98. LI JY, Park HSM, Huang G, Young MR, et al
    Prognostic Impact of Mismatch Repair Deficiency in High- and Low-Intermediate Risk, Early-Stage Endometrial Cancer Following Vaginal Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
99. LAKOMY DS, Wu J, Yoder AK, Hernandez M, et al
    Impact of Treatment Modality on Pelvic Floor Dysfunction for Uterine Cancer Survivors.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available
    
    
100. DONOVAN E, Albuquerque KV, Mantz CA, Beriwal S, et al
     The Role of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic and Oligoprogressive Gynecologic Malignancies: A Multi-Institutional Pooled Analysis.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
101. ROVIROSA A SR, Zhang Y, Chargari C, Cooper R, et al
     3D Image-Guided Brachytherapy as Only Treatment for Stage-I Inoperable Endometrial Cancer: Retrospective Analysis of the Gynecological Cancer GEC-ESTRO Working Group.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
102. NDUMBALO J, Muya S, Nyagabona SK, Yusuph S, et al
     Continuing Education Needs Identified During the Initial Experience of Delivering 3D Conformal Radiotherapy for Cervical Cancer Patients in Tanzania.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
103. YANEY A, Mladkova N, Quick AM
     Clinical and Genomic Determinants of Survival in Ugandan Women With Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
104. BHATIA R, Ramogola-Masire D, Friebel-Klingner T, Monare B, et al
     Cervical Cancer Screening in Botswana: An Urgent Call for Guideline Change.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
105. ZHANG Y, Liu C, Yang H, Shi M, et al
     Weekly Cisplatin vs. Triweekly Docetaxel Plus Cisplatin With Concurrent Chemoradiation in Post-Operative Treatment for Cervical Cancer With High-Risk Pathological Factors: A Randomized Controlled Phase III Trial From a Single Institution.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
106. LEUNG EW, Gladwish AP, Davidson MTM, Taggar A, et al
     Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus (SPARTACUS): A Multicenter Prospective Trial Evaluating Acute Toxicities and Patient Reported Outcomes.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
107. TARIQ M, Denniston KA
     EQD2 Dose Accumulation Based on Deformable Image Registration of HR-CTV, Bladder, Rectum and Bowel for Combined External-Beam Radiotherapy and Brachytherapy for Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
108. GAY C, Raphael Y, Steers J, Lu DJ, et al
     Ovarian Transposition Prior to Pelvic Radiotherapy: Spatial Distribution and Dose Volume Analysis.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
109. YEN A, Morgan HE, Wang K, Albuquerque KV, et al
     Interpretable Machine Learning Model Supported by Parallel Ensemble Learning to Predict Local Recurrence for Patients with Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
110. REIJTENBAGH DMW, Godart J, De Leeuw A, Seppenwoolde Y, et al
     A Machine-Learning Based Method for Inter-Institutional QA of MR-Based Brachytherapy Treatment Planning in Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
111. LIU C, Wang C, Hu X, Zou W, et al
     Dissecting Concurrent Chemoradiotherapy-Induced Landscape Alteration of Tumor Microenvironment in Locally Advanced Cervical Cancer at Single Cell Resolution.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
112. WANG W, Hu K, Zhang F
     Prophylactic Extended-Field Irradiation vs. Pelvic Irradiation in Cervical Cancer Patients With 2018 FIGO IIIC1 Diseases.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
113. HAN K, Fyles TW, Shek T, Croke JM, et al
     Chemoradiation With or Without Metformin in Locally Advanced Cervical Cancer: Phase II Randomized Trial.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
114. ROBIN TP, Hu J, Jones BL, Patton TJ, et al
     Phase I Dose Escalation Clinical Trial of Stereotactic Body Radiation Therapy (SBRT) for Limited Locoregional Recurrences of Ovarian Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
115. SPAMPINATO S, Jensen NBK, Potter R, Fokdal LU, et al
     Severity and persistency of late gastrointestinal morbidity in locally advanced cervical cancer: lessons learned from EMBRACE-I and implications for the future.
     Int J Radiat Oncol Biol Phys. 2021 Oct 19. pii: S0360-3016(21)02915.
     PubMed         Abstract available
     
     
116. LI J, Mao W, Li F, Ran L, et al
     A Phase II, Single-Arm, Prospective Clinical Trial for the Efficacy and Safety of Apatinib Combined With Capecitabine in Therapy for Recurrent/Metastatic and Persistent Cervical Cancer After Radiochemotherapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
117. WANG X, Ouyang G, Chen Z, Fu L, et al
     Automatic Contouring of the Clinical Target Volume (CTV) for Cervical Cancer Adjuvant Radiotherapy Using Deep Learning Algorithm.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
118. IKIZLER O, Ko HC
     Outcomes after Definitive Surgery +/- Adjuvant Treatment for Invasive and Non-Invasive FIGO Stage IA Malignant Mixed Mullerian Tumor of the Endometrium.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
119. HUI C, Mendoza M, Von Eyben R, Hammer P, et al
     Does Lymph Node Assessment Change the Prognostic Significance of Extensive LVSI and p53 Mutation in Endometrial Cancer?
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
120. MERFELD E, Huang JY, Kuczmarska-Haas A, Desai V, et al
     Targeting the GTV in Medically Inoperable Endometrial Cancer Using Brachytherapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
121. COOK AE, Ghanem AI, Hijaz M, Burmeister C, et al
     Patterns of Recurrence After Adjuvant Vaginal Cuff Brachytherapy and Chemotherapy in Early-Stage Uterine Serous Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
122. BYLUND KC, Chowdhry AK, Nguyen K, Geevarghese S, et al
     Effect of Adjuvant Radiation and Chemotherapy in Localized Uterine Carcinosarcoma: A National Cancer Database Analysis.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
123. CASPER AC, Parsons MW, Chipman J, Burt LM Jr, et al
     Risk of Secondary Malignancies in Ovarian Cancer Survivors: 54,305 Patients Analyzed With 40 Years of Follow-up.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
124. ANDERSON E, Luu M, Lu DJ, Chung EM, et al
     Pathologic Primary Tumor Factors Associated With Risk of Lymph Node Involvement in Patients With High-Risk Endometrial Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
125. POLLOCK AE, Risher H, Bentzen SM, Roque DM, et al
     Clinical Outcomes of Patients Treated With Intensity Modulated Proton Therapy (IMPT) Re-Irradiation for Gynecologic Malignancies.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
126. NGANGA D, Hoover A
     Visceral Adipose Volume as a Predictor for Acute Bowel Toxicity in Patients Receiving Adjuvant Intensity-Modulated Radiation Therapy for Cervical or Endometrial Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
127. PATEL G, Rivera A, Brodin P, Velten C, et al
     Outcomes of Definitive Radiation Therapy for Inoperable Endometrial Cancer and Dosimetric Comparison Study of HDR Brachytherapy vs. SBRT Boost.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
128. KAWAHARA D, Nishibuchi I, Kawamura M, Yoshida T, et al
     Radiomic Analysis for Pretreatment Prediction of Recurrence after Radiotherapy in Locally Advanced Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
129. HAMADE DF, Epperly M, Fisher R, Hou W, et al
     Second-Generation Probiotic Lactobacillus Reuteri Producing IL-22 (LR-IL-22) Protects the Intestine to Facilitate Whole Abdomen Irradiation (WAI) in Ovarian Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
130. YU E, DiPetrillo TA, Koffer PP, Miller CJ, et al
     Hospital Database Validation of PORTEC3 Stage-Based Overall Survival Benefit for Chemoradiation Therapy in Endometrial Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
131. WEIL C, Lew F, Gaffney DK, Suneja G, et al
     Patterns of Practice for Adjuvant Treatment of FIGO 1B Grade 3 Endometrial Adenocarcinoma Following Publication of ASTRO 2014 Guidelines for Postoperative Treatment in Women With Early Stage High Risk Endometrial Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
132. WANG W, Zou L, Wang T, Liu Z, et al
     Treatment Optimization of Pelvic External Beam Radiation With/or Vaginal Brachytherapy for Patients with Stage I to II High-Risk Endometrioid Adenocarcinoma: A Retrospective Multi-Institutional Analysis.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
133. SUN S, Zou L, Wang T, Liu Z, et al
     Age >/=60 y May Not be an Appropriate Adverse Risk Factor in Adjuvant Treatment of Patients With Early-Stage Endometrial Carcinoma: A Multi-Institutional Analysis in China.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
134. RUSSO AL, Bernstein KD, Nisbet SP, Horick N, et al
     Phase II Study of Adjuvant Scanned Proton Beam Radiation Therapy for Node-positive Cancer of the Uterus and Cervix.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
135. REN K, Zou L, Wang T, Li X, et al
     Long-Term Outcome and Failure Patterns in Early-Stage Endometrial Cancer After Postoperative Adjuvant Radiotherapy: A Multi-Institutional Analysis Update Data.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
136. CORRIGAN KL, Yoder AK, Lin LL, Jhingran A, et al
     Long-Term Survival Following Definitive Radiation Therapy for Oligometastases in Gynecological Malignancies: A Landmark Analysis.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
137. ZHOU Z, Zhang F, Hu K
     High Dose Radiotherapy Combined With TGF-beta Blocking Alleviate Cervical Cancer Cell-Suppressed Dendritic Cell Homing Through PGE2 Pathway.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
138. AMARNATH SR
     Is Inflammatory Bowel Disease a Contraindication for Pelvic XRT in Patients With Gynecologic Cancers? Efficacy and Toxicity Outcomes in the Modern Era.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
139. PACHIGOLLA SL, Markovina S, Lin AJ, Schwarz JK, et al
     Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Locally Advanced Cervical Cancer Not Amenable to Brachytherapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
140. ONAL C, Guler OC, Reyhan M, Yapar AF, et al
     Long-Term Outcomes of Cervical Cancer Patients With Complete Metabolic Response After Definitive Chemoradiotherapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
141. PACHIGOLLA SL, Massad LS, Thaker P, Mutch D, et al
     A Nomogram Predicting Early Cervical Cancer Distant Recurrence.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
142. OKONOGI N, Ando K, Murata K, Wakatsuki M, et al
     The Clinical Results in Multi-Institutional Retrospective Analysis of Carbon-Ion Radiotherapy for Patients With Locally Advanced Adenocarcinoma of the Uterine Cervix.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
143. NISHIBUCHI I, Kawahara D, Kawamura M, Kubo K, et al
     A Prediction Model for Para-Aortic Lymph Node Metastasis in Cervical Cancer by Radiomics Analysis Using Pre-Treatment MRI Images of the Primary Tumor.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
144. PUENTES CYM, Banks T, Hrycushko BA, Jia X, et al
     Multidisciplinary Consensus and Evaluation of Gynecological High-Dose-Rate (HDR) Brachytherapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
145. LIU C, Li A, Wang C, Zou W, et al
     Intratumor Microbiome and Its Correction With Tumor Response After Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
146. LI F, Li J, Yin S, Mei F, et al
     A Phase III Prospective Randomized Controlled Clinical Trial for the Efficacy and Safety of Neoadjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer (Lump >/=4 cm).
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
147. PINTO PJJ, Favareto SL, Souza CFPM, Baiocchi G, et al
     Do Radiotherapy Planning Factors Influence Para-Aortic Recurrence in IIIC1 Cervical Cancer Patients?
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
148. RAHIMY E, Von Eyben R, Lewis J, Hristov DH, et al
     Dosimetric and Metabolic Parameters Predictive of Hematologic Toxicity in Cervical Cancer Patients Undergoing Definitive Chemoradiotherapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
149. SHI V, Huang Y, Grigsby PW, Markovina S, et al
     Serum SCCA as an Early Indicator of Recurrence in Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
150. YANG H, Zhang Y, Liu C, Zhao L, et al
     Combined Modality of Bevacizumab With Radical Radiotherapy and Chemotherapy in the Treatment of Refractory Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
151. WU J, Lakomy DS, Fellman B, Salcedo MP, et al
     Bone Mineral Density Changes Within and Outside of RT Fields Used to Treat Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
152. WILLIAMSON CW, Kotha NV, Morris K, Simoes-Torigoe R, et al
     Radiation-Induced Vaginal Stenosis in Patients With Locally Advanced Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
153. WEIL C, Parsons MW, Chipman J, Kraus RD, et al
     Secondary Malignancy Risk in Cervical Cancer Survivors After 40 Years of Follow-Up Stratified by Treatment Modality and Radiation Technique.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
154. WANG D, Hu K, Zhang F
     Impact of Body Mass Index and Abdominal Subcutaneous Fat Thickness of Setup Errors in Postoperative Cervical Cancer Patients Underwent Daily Image-Guided Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
155. WEI C, Franco II, Orio PF 3rd, Mak RH, et al
     Comparison of Cost vs. Reimbursement for Definitive Radiotherapy in Locally Advanced Cervical Cancer Using Time-Driven Activity-Based Costing.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
156. THOMAS RJ, Provenzano D, Goyal S, Loew M, et al
     Trends in Guideline-Adherent Chemoradiation Therapy for Locally Advanced Cervical Cancer Before and After the Affordable Care Act.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     
157. SAITO AI
     Curative Radiotherapy for Stage IVB or Recurrent Uterine Cancer Presenting With Supraclavicular or Mediastinal Lymph Node Metastasis.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed         Abstract available
     
     

     
     J Clin Endocrinol Metab

158. LEMAITRE M, Ternynck C, Bourry J, Baudoux F, et al
     Association between HbA1c levels on adverse pregnancy outcomes during pregnancy in type 1 diabetic patients.
     J Clin Endocrinol Metab. 2021 Oct 25. pii: 6409789. doi: 10.1210.
     PubMed         Abstract available
     
     
159. STUENKEL CA, Gompel A, Davis SR, Pinkerton JAV, et al
     Approach to the Patient with New Onset Secondary Amenorrhea: Is This Primary Ovarian Insufficiency?
     J Clin Endocrinol Metab. 2021 Oct 25. pii: 6409726. doi: 10.1210.
     PubMed         Abstract available
     
     
160. TEEDE HJ, Garad RM, Melder A, Norman RJ, et al
     Letter to the Editor from Teede: "Clinical Practice Guidelines on the Diagnosis and Management of Polycystic Ovary Syndrome: A Systematic Review and Quality Assessment Study".
     J Clin Endocrinol Metab. 2021 Oct 22. pii: 6408638. doi: 10.1210.
     PubMed        
     
     

     
     J Urol

161. DALLAS K, Taich L, Kuhlmann P, Rogo-Gupta L, et al
     Supracervical Hysterectomy is Protective Against Mesh Complications After Robotic-Assisted Abdominal Sacrocolpopexy: A Population Based Cohort Study of 12,189 Patients.
     J Urol. 2021 Oct 25:101097JU0000000000002262. doi: 10.1097/JU.0000000000002262.
     PubMed         Abstract available
     
     
162. DE LA CALLE CM, Patel SH, Kates M
     Contemporary Rates of Gynecologic Organ Involvement in Females With Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy. Letter.
     J Urol. 2021 Oct 25:101097JU0000000000002306. doi: 10.1097/JU.0000000000002306.
     PubMed        
     
     
163. BREE KK, Navai N
     Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy. Reply.
     J Urol. 2021 Oct 25:101097JU0000000000002307. doi: 10.1097/JU.0000000000002307.
     PubMed        
     
     

     
     JAMA

164. DODD JM, Dalrymple K, Louise J
     Systematic Review of Counseling and Behavioral Interventions for Healthy Weight and Weight Gain in Pregnancy From the US Preventive Services Task Force.
     JAMA. 2021;326:1634-1635.
     PubMed        
     
     
165. CANTOR AG, Jungbauer RM, Chou R
     Systematic Review of Counseling and Behavioral Interventions for Healthy Weight and Weight Gain in Pregnancy From the US Preventive Services Task Force-Reply.
     JAMA. 2021;326:1635-1636.
     PubMed        
     
     
166. HOWARD JT, Sparks CS, Santos-Lozada AR, Olowolaju SA, et al
     Trends in Mortality Among Pregnant and Recently Pregnant Women in the US, 2015-2019.
     JAMA. 2021;326:1631-1633.
     PubMed        
     
     

     
     Lancet

167. THE LANCET
     Abortion bans in the USA harm health equity.
     Lancet. 2021;398:1461.
     PubMed        
     
     

     
     Obstet Gynecol

168. ELBAUM CC, Harris JA
     Disparities in Access to High-Volume Surgeons Within High-Volume Hospitals for Hysterectomy.
     Obstet Gynecol. 2021;138:819.
     PubMed        
     
     
169. LOPEZ CL, Chen MJ
     Promoting Diversity, Equity, and Inclusion in the Selection of Obstetrician-Gynecologists.
     Obstet Gynecol. 2021;138:820.
     PubMed        
     
     

     
     PLoS Comput Biol

170. ZHU K, Cai L, Cui C, de Los Toyos JR, et al
     Single-cell analysis reveals the pan-cancer invasiveness-associated transition of adipose-derived stromal cells into COL11A1-expressing cancer-associated fibroblasts.
     PLoS Comput Biol. 2021;17:e1009228.
     PubMed         Abstract available
     
     

     
     PLoS One

171. BROWN NB, Peragine D, VanderLaan DP, Kingstone A, et al
     Cognitive processing of sexual cues in asexual individuals and heterosexual women with desire/arousal difficulties.
     PLoS One. 2021;16:e0251074.
     PubMed         Abstract available
     
     
172. OKAFOR OC, Ezemba N, Onyishi NT, Ezike KN, et al
     Improving the diagnostic recognition of thoracic endometriosis: Spotlight on a new histo-morphological indicator.
     PLoS One. 2021;16:e0251385.
     PubMed         Abstract available
     
     
173. BARCA J, Meikle A, Bouman M, Gnemmi G, et al
     Effect of pegbovigrastim on clinical mastitis and uterine disease during a full lactation in grazing dairy cows.
     PLoS One. 2021;16:e0252418.
     PubMed         Abstract available
     
     
174. BAILLEUL A, Niro J, Du Cheyron J, Panel P, et al
     Infertility management according to the Endometriosis Fertility Index in patients operated for endometriosis: What is the optimal time frame?
     PLoS One. 2021;16:e0251372.
     PubMed         Abstract available
     
     
175. FILARDO S, Di Pietro M, Pasqualetti P, Manera M, et al
     In-cell western assay as a high-throughput approach for Chlamydia trachomatis quantification and susceptibility testing to antimicrobials.
     PLoS One. 2021;16:e0251075.
     PubMed         Abstract available
     
     
176. OYAMA Y, Shigeta S, Tokunaga H, Tsuji K, et al
     CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents.
     PLoS One. 2021;16:e0251079.
     PubMed         Abstract available
     
     

     
     Urol Clin North Am

177. MATTAWANON N, Charoenkwan K, Tangpricha V
     Sexual Dysfunction in Transgender People: A Systematic Review.
     Urol Clin North Am. 2021;48:437-460.
     PubMed         Abstract available
     
     
178. SIEGAL A, Chubak BM
     Pharmaceutical and Energy-Based Management of Sexual Problems in Women.
     Urol Clin North Am. 2021;48:473-486.
     PubMed         Abstract available
     
     
179. ULOKO M, Rubin R
     Managing Female Sexual Pain.
     Urol Clin North Am. 2021;48:487-497.
     PubMed         Abstract available
     
     
180. GOLDMAN M, Abel MK
     Oncology Survivorship and Sexual Wellness for Women.
     Urol Clin North Am. 2021;48:499-512.
     PubMed         Abstract available
     
     
181. SALTER CA, Mulhall JP
     Oncosexology: Sexual Issues in the Male Cancer Survivor.
     Urol Clin North Am. 2021;48:591-602.
     PubMed         Abstract available
     
     
182. WITTMANN D, Bober SL
     Incorporating the Principles of Sex Therapy into Urologic Care.
     Urol Clin North Am. 2021;48:425-436.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: